Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1444930906
总结
CYP2D6 *4 is not associated with increased likelihood of Recurrence when treated with antineoplastic agents and tamoxifen in women with Breast Neoplasms as compared to CYP2D6 *1.